drug adverse effects of EGF receptor inhibitors
Jump to navigation
Jump to search
Adverse effects
- rash (acneiform eruption)
- topical clindamycin 2% plus hydrocortisone 1% lotion BID until resolution of the rash, plus minocycline 100 mg PO BID for a minimum of 4 weeks & continuing until resolution of the rash (NGC [CancerControl Alberta])[1]
- paronychia[1]
- interstitial lung disease[2]
More general terms
References
- ↑ 1.0 1.1 1.2 Medical Knowledge Self Assessment Program (MKSAP) 17, American College of Physicians, Philadelphia 2015
- ↑ 2.0 2.1 Rosell R, Carcereny E, Gervais R et al Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol. 2012 Mar;13(3):239-46. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22285168 Clinical Trial.